NCT00957437View on ClinicalTrials.gov

Study to Assess Drug Concentrations in Plasma of Different Extended-release Formulations of AZD1305

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

August 31, 2009

Study Completion Date

November 30, 2009

Conditions

Healthy

Interventions

DRUG

AZD1305

Single Oral Dose, ER formulation 1

DRUG

AZD1305

ER formulation 1, bid for 5 days

DRUG

AZD1305

Single Oral Dose, ER formulation 2

Trial Locations (1)

Unknown

Research Site, Harrow

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY

NCT00957437 - Study to Assess Drug Concentrations in Plasma of Different Extended-release Formulations of AZD1305 | Biotech Hunter | Biotech Hunter